Literature DB >> 19542177

Mouse strain determines the outcome of wound healing after myocardial infarction.

Susanne W M van den Borne1, Veerle A M van de Schans, Agnieszka E Strzelecka, Helena T M Vervoort-Peters, Peter M Lijnen, Jack P M Cleutjens, Jos F M Smits, Mat J A P Daemen, Ben J A Janssen, W Matthijs Blankesteijn.   

Abstract

AIMS: Our objective was to study the effect of the genetic background on the wound healing process after myocardial infarction (MI) in mice. METHODS AND
RESULTS: MI was induced in five different mouse strains (BalbC, C57Bl6, FVB, 129S6, and Swiss). At 3, 14, and 28 days after MI, cardiac dimensions were monitored by echocardiography and histology, whereas cardiac function was determined by direct intraventricular pressure measurements (dP/dt). Furthermore, matrix metalloproteinases were measured by zymography, and mRNA expression by quantitative PCR. Infarct rupture, which typically occurred at 3-6 days post-MI, was most frequent in 129S6 mice (62%), followed by C57Bl6 (36%), FVB (29%), Swiss (23%), and BalbC (5%). The high incidence of infarct rupture in 129S6 mice was associated with high systolic blood pressure and increased influx of inflammatory cells. Cardiac dilatation was most marked in Swiss mice and least prominent in 129S6 mice. The degree of dilatation was associated with a reduced ejection fraction and decreased dP/dt values at 14 and 28 days post-MI. At day 14 and 28 post-MI, secondary thinning of the infarct area was marked in BalbC, FVB, and Swiss, but absent in C57Bl6 and 129S6 mice. In the latter two groups, this was paralleled by the highest number of myofibroblasts at day 14 post-MI.
CONCLUSION: The outcome of infarct healing in mice strongly depends on genetic background. On the basis of our results, we suggest that for studies on infarct rupture, the 129S6 mouse is the background of choice, whereas BalbC and Swiss mice are the preferred models to study infarct thinning post-MI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542177     DOI: 10.1093/cvr/cvp207

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  83 in total

1.  Is it time to consider ethnicity in treatment guidelines?

Authors:  Bryony M Mearns
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

Review 2.  Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.

Authors:  Junxi Wu; Jun Li; Nannan Zhang; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-03-23       Impact factor: 17.165

3.  Protein kinase C binding protein 1 inhibits hypoxia-inducible factor-1 in the heart.

Authors:  Kathryn J Schunke; Chad B Walton; David R Veal; Chrisy T Mafnas; Cynthia D Anderson; Allison L Williams; Ralph V Shohet
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

4.  Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction.

Authors:  Yutaka Matsui; Junko Morimoto; Toshimitsu Uede
Journal:  World J Biol Chem       Date:  2010-05-26

5.  Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke.

Authors:  Hua Zhang; Pranay Prabhakar; Robert Sealock; James E Faber
Journal:  J Cereb Blood Flow Metab       Date:  2010-02-03       Impact factor: 6.200

Review 6.  Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction.

Authors:  Mingyuan Huang; Du Yang; Meixiang Xiang; Jianan Wang
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

Review 7.  NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury.

Authors:  Pamela W M Kleikers; K Wingler; J J R Hermans; I Diebold; S Altenhöfer; K A Radermacher; B Janssen; A Görlach; H H H W Schmidt
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

Review 8.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

9.  UM206, a selective Frizzled antagonist, attenuates adverse remodeling after myocardial infarction in swine.

Authors:  André Uitterdijk; Kevin C M Hermans; Daphne P M de Wijs-Meijler; Evangelos P Daskalopoulos; Irwin K Reiss; Dirk J Duncker; W Matthijs Blankesteijn; Daphne Merkus
Journal:  Lab Invest       Date:  2015-12-14       Impact factor: 5.662

10.  Myocardial stress remodelling after regional infarction is independent of glycogen synthase kinase-3 inactivation.

Authors:  Ian G Webb; Pierre Sicard; James E Clark; Simon Redwood; Michael S Marber
Journal:  J Mol Cell Cardiol       Date:  2010-08-06       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.